| pubmed-article:17371004 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17371004 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:17371004 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
| pubmed-article:17371004 | lifeskim:mentions | umls-concept:C0733755 | lld:lifeskim |
| pubmed-article:17371004 | lifeskim:mentions | umls-concept:C1333707 | lld:lifeskim |
| pubmed-article:17371004 | lifeskim:mentions | umls-concept:C1709915 | lld:lifeskim |
| pubmed-article:17371004 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:17371004 | pubmed:dateCreated | 2007-4-12 | lld:pubmed |
| pubmed-article:17371004 | pubmed:abstractText | A 4-aminopiperidine-4-carboxylic acid residue was placed in the pTyr+1 position of a Grb2 SH2 domain-binding peptide to form a general platform, which was then acylated with a variety of groups to yield a library of compounds designed to explore potential binding interactions, with protein features lying below the betaD strand. The highest affinities were obtained using phenylethyl carbamate and phenylbutyrylamide functionalities. | lld:pubmed |
| pubmed-article:17371004 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17371004 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17371004 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17371004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17371004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17371004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17371004 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17371004 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17371004 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17371004 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:BurkeTerrence... | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:FisherRobert... | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:OishiShinyaS | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:NicklausMarc... | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:LeeKyeongK | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:ChoiWon JunWJ | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:WorthyKaren... | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:KarkiRajeshri... | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:KangSang-UkSU | lld:pubmed |
| pubmed-article:17371004 | pubmed:author | pubmed-author:BinduLakshman... | lld:pubmed |
| pubmed-article:17371004 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17371004 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:17371004 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:17371004 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17371004 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17371004 | pubmed:pagination | 1978-82 | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:meshHeading | pubmed-meshheading:17371004... | lld:pubmed |
| pubmed-article:17371004 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17371004 | pubmed:articleTitle | Examination of acylated 4-aminopiperidine-4-carboxylic acid residues in the phosphotyrosyl+1 position of Grb2 SH2 domain-binding tripeptides. | lld:pubmed |
| pubmed-article:17371004 | pubmed:affiliation | Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702-1201, USA. | lld:pubmed |
| pubmed-article:17371004 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17371004 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17371004 | lld:chembl |
